Bronchiolitis

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Continuous pulse oximetry monitoringN/A1 trial
Active Trials
NCT01014910CompletedEst. Sep 2014
Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
The new HFNC weaning protocolN/A1 trial
Active Trials
NCT06621641CompletedEst. Jun 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Hamilton medicalThe new HFNC weaning protocol
City TherapeuticsContinuous pulse oximetry monitoring

Clinical Trials (2)

NCT06621641Hamilton medicalThe new HFNC weaning protocol

Nurse-led High-flow Nasal Cannula Weaning Protocol in Pediatric Intensive Care Unit

Start: Oct 2024Est. completion: Jun 2025
N/ACompleted
NCT01014910City TherapeuticsContinuous pulse oximetry monitoring

Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis

Start: Dec 2009Est. completion: Sep 2014
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space